- Methods and Strategies to Advance the Safety and Regulatory Compliance of Consumer and Nonconsumer Products Sold in the United States Using Hazard-Based or Risk-Based Approaches
-
Stars at Night Ballroom B2‚ Convention Center
Chair: Margaret Whittaker, ToxServices LLC
Co-Chair: Terra Vincent-Hall, NSF
Primary Endorser: Regulatory and Safety Evaluation Specialty Section
Endorser(s): Risk Assessment Specialty Section
Endorser(s): Sustainable Chemicals through Contemporary Toxicology Specialty SectionConsumers purchase thousands of different products such as foods, beverages, dietary supplements, toys, apparel, cosmetics, cleaning products, and appliances, among others. Such products are often parsed into consumer and non-consumer product categories for purposes of federal regulation and oversight, but many share the characteristic of containing chemicals of concern. U.S. EPA's Chemical Data Reporting database indicates that at least 8,600 chemicals (as of the most recent reporting year, 2024) are in current use domestically or are imported, with more than half of these chemicals used in consumer product applications, establishing that products purchased by consumers are replete with chemicals. To ensure that products in the marketplace do not harm consumers and comply with U.S. federal and state-level regulations and/or meet certification standard requirements, most products undergo a safety assessment to establish no significant risk of harm from chemical and/or physical hazards associated with a specific product under intended use conditions.
This session will focus on best practices to assess health hazards and/or risks for a diverse group of product types. Presentations will cover: strategies and initiatives to identify and reduce human health and environmental hazards throughout the supply chain using a hazard-based approach; case studies demonstrating derivation of California Proposition 65 No Significant Risk Levels (NSRLs) for carcinogens and Maximum Allowable Dose Levels (MADLS) for reproductive/developmental toxicants; best practices to assess health risks from constituents of dietary supplements and nutraceuticals; and case studies on consumer product exposure and risk assessment practices at the U.S. Consumer Product Safety Commission (CPSC). Following the presentations, the panel will discuss: the merits of hazard vs. risk-based safety evaluation approaches; recent developments in the use of QSAR and read-across tools to identify acceptable points of departure for human health risk assessment; and exposure assessment approaches relevant to assessing consumer health risks.
Session and Activity Type
Enter Note
Go to previous page in this tab
Event
